AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/306% below fair value
$11.98−0.44 (-3.50%)
Close on Nov 12, 2026Market cap $504.02MP/E –Yield –
AngioDynamics r&d expenses
Research and development expenses are spending on new products and technology.
AngioDynamics's R&D Expenses for the twelve months ending Aug 31, 2026 was $31.01M, up 17.7% year over year. For fiscal 2026 it was $29.45M, up 12.3% from the year before. Over ten years it grew 1.6% a year on average. The highest annual figure on record is $36.39M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $29.45M | +12.3% |
| FY2025 | May 31, 2025 | $26.22M | -16.8% |
| FY2024 | May 31, 2024 | $31.51M | +5.5% |
| FY2023 | May 31, 2023 | $29.88M | -2.8% |
| FY2022 | May 31, 2022 | $30.74M | -15.5% |
| FY2021 | May 31, 2021 | $36.39M | +22.6% |
| FY2020 | May 31, 2020 | $29.68M | +5.0% |
| FY2019 | May 31, 2019 | $28.26M | +16.1% |
| FY2018 | May 31, 2018 | $24.34M | +0.8% |
| FY2017 | May 31, 2017 | $24.15M | -3.6% |
| FY2016 | May 31, 2016 | $25.05M | -5.8% |
| FY2015 | May 31, 2015 | $26.59M | -5.4% |
| FY2014 | May 31, 2014 | $28.12M | +7.8% |
| FY2013 | May 31, 2013 | $26.09M | +27.2% |
| FY2012 | May 31, 2012 | $20.51M | -4.0% |
| FY2011 | May 31, 2011 | $21.37M | +10.9% |
| FY2010 | May 31, 2010 | $19.28M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $7.98M | +24.3% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $8.18M | +24.1% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $7.08M | +2.5% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $7.77M | +20.7% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $6.42M | +2.1% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $6.59M | -2.0% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $6.91M | -15.6% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $6.43M | -25.7% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $6.29M | -20.9% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $6.72M | -14.5% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $8.19M | +19.5% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $8.66M | +26.6% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $7.94M | -4.7% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $7.86M | -0.1% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $6.85M | -5.9% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $6.84M | -16.6% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $8.33M | +12.7% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $7.87M | -13.6% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $7.28M | -15.0% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $8.20M | -15.6% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $7.39M | -17.9% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $9.10M | +25.9% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $8.57M | +2.0% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $9.71M | +25.1% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $9.01M | +43.2% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $7.23M | +4.9% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $8.40M | +21.4% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $7.76M | +9.7% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $6.29M | -14.7% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $6.89M | +29.3% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $6.92M | +7.1% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $7.08M | +15.9% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $7.37M | +14.5% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $5.33M | -4.3% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $6.46M | +8.5% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $6.11M | +3.3% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $6.44M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $5.58M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $5.95M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $5.91M | – |
See a number that looks wrong?